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Renal biopsy collagen I mRNA predicts scarring in rabbit anti-GBM
disease: Comparison with conventional measures. Progressive loss of
normal structure associated with scarring is the hallmark of chronic
diseases of most organs. To test the hypothesis that measurement of
interstitial collagen mRNA levels would he a useful index to predict future
scarring, we developed an assay to quantitate ai(I) procollagen mRNA
factored for GAPDH mRNA using RT-PCR (the "CI:G ratio"). We first
defined conditions under which the assay could he used for analysis of
renal biopsy samples. The Ci:G ratio was then used to determine whether
mRNA measurements performed at an early stage of inflammation (day
7) in a model of anti-GBM disease in the rabbit would predict outcome at
day 30 as measured by interstitial and glomerular scarring and renal
cortical hydroxyproline accumulation. The predictive value of this assay
was compared to functional (serum creatinine and urine protein:creati-
nine ratio) and histologic (glomerular and interstitial scoring) parameters
also measured at day 7. We found that the CI:G ratio alone provided a
sensitive and discriminating assay over a wide range of renal injury that
predicted various parameters of scarring with an average coefficient of
determination (r2) of 0.69. This predictive power was higher than that
found for conventional measures, which tended to have good discrimina-
tory capacity over limited ranges of renal injury. The CI:G ratio provided
significant additional predictive power over and above that available from
combinations of conventional functional or histologic parameters. We
conclude that measurement of the CI:G ratio in biopsy samples deserves
further assessment as a potentially useful quantitative predictor of Out-
come that could lead to improved clinical decision-making.
Interstitial fibrosis is the most powerful predictor of progression
to end-stage renal disease (ESRD) regardless of the etiology of
renal injury [1—4]. Progression to ESRD requiring dialysis or
transplantation is expensive (costing approximately $50,000US
per patient per year) as well, as carrying high morbidity and
mortality (50% three year mortality in the U.S.) [5]. Therapeutic
options are available for preventing progression of fibrosis. How-
ever, current approaches carry side effects and complications that
make their use unwarranted unless the physician can be confident
that the risk of treatment is justified by a greater risk of progres-
sion to ESRD. Methodologies currently available to the physician
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have rather weak prognostic capability. Functional measurements
currently in use are insensitive and nonspecific [6—91. To improve
prognostic power, histologic scoring systems have been estab-
lished that include measures of the extent of old and established
injury (chronicity index) as well as the severity of current injury
(activity index) [10]. However, these systems are complex to use
and observer-dependent. If we are to make progress in preventing
renal failure, we must develop better means of identi'ing and
monitoring those individuals at risk for progression.
Since the fibrotic process is the principle indicator of irrevers-
ible progression, we have mapped the fibrotic response to glomer-
ular inflammation in a model of interstitial and glomerular fibrosis
induced by anti-GBM antibody in the rabbit [11—17]. Collagen I
mRNA was found to be increased by day 4 after injection of
anti-GBM antibody [121, and this early increase in collagen I
mRNA was localized to the interstitial (extraglomerular perivas-
cular) compartment by in situ hybridization [12, 13]. Collagen I
mRNA levels peaked by day 7 and had returned to towards
baseline by day 30. Activated fibroblasts were observed in the
interstitial compartment and apparently migrating through holes
in Bowman's capsule as they moved into the glomerulus to
contribute to the formation of the fibrous crescent [13]. The major
mediator driving collagen synthesis was identified as TGFI3 [14].
The major chemotactic factor for fibroblasts was identified as
fibronectin fragments [15]. Fibronectin rapidly accumulates in
glomeruli from plasma during inflammation where it is rapidly
degraded [16]. Fibronection is also synthesized in glomeruli
during crescent formation [17]. The fibrotic response to inflam-
mation in this model has thus been carefully characterized and
can be used to develop and test novel approaches to predicting
progression.
In designing an assay system that would allow prediction of
fibrosis we focused on the interstitial collagens for several reasons.
First, there is substantial evidence linking poor prognosis with
interstitial matrix accumulation in the kidney, even in those
conditions thought to be of primarily non-interstitial (such as
glomerular or vascular) origin [1—41. Second, our previous studies
in the rabbit had showed that the normal level of mRNA for type
I collagens in renal cortex were low [12, 13]. For example, it
appeared to be lower than that of the al(IV) basement membrane
collagen level [12]. We therefore anticipated that small changes in
levels of collagen mRNA would be easily detected above a low
basal level. Third, we have shown that changes in interstitial
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collagen mRNA occurs early in inflammatory renal disease [12,
13]. Fourth, we found that ai(I) mRNA levels in renal cortex
increased markedly (at least 18-fold) in the model [12], suggesting
that large changes in collagen I mRNA could be expected in renal
diseases. We thus expected to be able to measure large increases
in collagen I mRNA in disease states against a low basal level.
Quantitative RT-PCR approaches to matrix synthesis have
previously been used to measure mRNA levels in renal cortical
tissues [18—21], and the suggestion has been made that this
approach could be clinically useful [22]. We sought to design,
build and validate a quantitative RT-PCR assay using PCR
primers that would amplify human collagen I cDNAs as well as
collagen I cDNAs from animals commonly used in experimental
systems (rabbit, rat and mouse). This would allow cross-validation
studies between experimental animals and humans. We then
wanted to test the potential usefulness of the assay with the
concept that to be clinically worthwhile the assay would need to
provide quantitative information not already available to the
clinician through conventional clinical measures of function or
structure.
METHODS
cDNA library screening, cloning and sequencing
An oligo(dT)- and random-primed cDNA library in A-Zap
(Stratagene, La Jolla, CA, USA) prepared from seven-day rabbit
renal cortex was screened as previously described [23] with a
human al(I) eDNA (I-1f677; the generous gift of Francis Ramirez
[24—26]). In brief, 400,000 recombinant phage plated and repli-
cate filter lifts were prepared. DNA was denatured and fixed in
vacuo at 80°C prior to hybridization. Filters were prehybridized in
0.9 M NaCI, 0.09 M sodium citrate, pH 7.0, 0.5% SDS, 0.1% ficoll,
0.1% polyvinylpyrrolidine, 0.1% BSA at 65°C for two hours before
the addition of labeled denatured cDNA probe at I X 106
dpm/ml. After 16 hours, the filters were washed three times at
65°C with 0.3 M NaCl, 30 m sodium citrate, pH 7.0, 0.5% SDS
and twice at 37°C in 15 mivi NaC1, 1.5 m sodium citrate, pH 7.0,
0.5% SDS before autoradiographs were prepared. Nine recombi-
nant phages were plaque purified and the cDNA inserts were
subcloned into the EcoRI site of pBluescript. One of these, 23
SK-2a, was approximately 3 kb in length. A 0,67 kb XhoI-EcoRI
fragment from this clone was sequenced in its entirety on both
strands using synthetic oligonucleotide primers.
RNA isolation
Kidneys were sliced in the coronal plane and tissue correspond-
ing to the renal capsule, cortex with the renal capsule, cortex
without capsule, outer medulla or inner medulla were dissected,
weighed and snap frozen in guanidine isothiocyanate (10 ml/g of
wet tissue weight). Needle biopsy samples were prepared from
renal cortex using a Biopty gun (20, 18 and 16 gauge) and 1 to 2
mm long samples were placed in guanidinc isothiocyanatc solu-
tion and snap frozcn. Samples were thawed at 0°C and dispersed
by homogenization or sonication, and total RNA was extracted
using a commercially available modification of the acid-phenol
method (RNAz0I; Tel-Test, Inc., Fricndswood, TX, USA) [27].
Northern hybridization
Denatured total RNA from various renal tissue samples were
resolved on 2.2 M formaldehyde, 1% agarose gels and transferred
by capillary blotting to Zetabind filters (CUNO, Meriden, CT,
USA). Filters were stained with methylene blue, to check the
integrity, uniformity of loading and transfer of RNA, prior to
fixation in vacuo at 80°C for two hours. Filters were prehybridized
at 65°C in 0.5 M NaH2PO4, pH 7.0, 1 mM EDTA, 7% SDS, and 1%
BSA for 4 to 6 hours before adding denatured probe (2 x 106
dpm/ml). After 18 hours, filters were washed two times with 40
mM NaH2PO pH 7.0, 1 mvt EDTA and 7% SDS at 65°C, and four
times with 40 ms't NaH2PO4, pH 7.0, 1 m'vi EDTA, and 1% SDS
at 65°C, before exposure to preflashed film (X-Omat AR; East-
man-Kodak, Rochester, NY, USA) at —80°C. Purified cDNA
inserts encoding rabbit al(I), a2(I) [13] and human glyceralde-
hyde-3-phosphate dehydrogenase (GAPDH) [28, 29] were labeled
with [a32P]dCTP (3000 Ci/mM; Amersham, Arlington Heights, IL,
USA) to a specific activity of i0 dpm4tg using random primers
[30], and separated from unincorporated nucleotides by gel
filtration.
Synthetic oligonucleotide synthesis
All synthetic oligonucleotides were synthesized by the DNA
Synthesis Core Facility, a part of the University of Michigan's
Biomedical Research Core Facilities, on automated DNA synthe-
sizers (Applied Biosystems, Inc., Foster City, CA, USA) employ-
ing f3-cyanoethyl phosphoramidite chemistry on controlled pore
glass support. The oligonucleotides used were as follows:
al(I) sense 5'GATGTGCCACTCTGACTGG3';
a 1(1) anti-sense 5 'ACATCGATGATGGGCAGGC3';
a2(I) sense 5'GCATTGCATAATGGATGAGG3';
a2(I) anti-sense S 'GCACAATGCTCTGATCAATCC3';
GAPDH sense 5 'TCACCATCTTCCAGGAGCG3';
GAPDH anti-sense 5 'CTGCTV['CACCACCTFCTITGA3'.
Mutant template construction
Deletion mutants for rabbit al(I), a2(l) and human GAPDH
were prepared by recombinant PCR using two complementary
primers [31]. The mutant PCR product was subcloned in pBlue-
script KSM13 (Stratagene) and verified by nucleotide sequenc-
ing as described above.
Complementary DNA synthesis
Oligo(dT) (0.5 tg; Boehringer-Mannheim, Indianapolis, IN,
USA) was annealed to total RNA (20 jg from large samples, all
of the RNA recovered in the case of biopsy samples) after
denaturation at 70°C and eDNA was synthesized at 42°C for one
hour using 100 U of Superscript (BRL, Gaithersburg, MD, USA),
in a final volume of 20 .tl of the vendor's buffer supplemented with
20 U RNAsin (Prornega Biotech, Madison, Wi, USA). cDNA was
precipitated and dissolved in 1 msi EDTA, 10 m'vi Tris, pH 7.4.
Qua ntitation of eDNA by polymerase chain reaction (PCR)
The approaches used were as previously described [31—36].
Serial log dilutions of each eDNA were prepared and analyzed to
determine the dilution within the linear range of each mutant
template. PCR reactions were optimized as to pH and Mg2
concentration for each primer pair. Each 25 jil reaction was
performed in a 500 1.d tube containing 15 mrvi (NH4)2S04, 60 mM
Tris-HCI, pH 8.5 to 9.5, 2.0 to 2.5 mi MgCl2, 0.25 mM dNTP, 6.25
M of each primer, 0.625 U AmpliTaq (Perkin-Elmer Cetus,
Norwalk, CT, USA) containing 0.5 jiCi [a32P]dCTP (3000 Ci/mM;
Amersham, Arlington Heights, IL, USA), an appropriate dilution
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Table 1. Effect of sample size and severity of injury on the values obtained for the CI:G ratio in the model of rabbit anti-GBM disease
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2.0 mg Mild 1.88, 1.48, 1.86, 1.60, 1.82, 2.19, 1.97 1.83 0.23 12.7
of wild type eDNA and 125, 250, 500, 1,000, 2,000 or 3,000 copies
of mutant template. The optimum Mg concentrations and pHs for
each primer pair were as follows: al(I), 2.0 mrvi Mg2, pH 9.5;
a2(I), 2.5 mM Mg2, pH 8.5; or GAPDH, 2.0 mM Mg2, p1-1 9.0.
After an initial denaturation at 94°C for 3.5 minutes, reactions
were amplified in a thermal cycler (Coy Laboratory Products, Ann
Arbor, MI, USA) with cycles of 94°C for 3.5 minutes, 54°C for 1.5
minutes and 72°C for 1.5 minutes. After 30 cycles, a final
extension at 72°C for eight minutes was performed. Amplification
of csl(I), cr2(I) and GAPDH was performed in parallel for each
sample. In every experiment, H20 and reverse transcription
controls for contamination were performed.
Quantitation of wild type and mutant cDNAs
An aliquot of each reaction was resolved by electrophoresis in
5% polyacrylamide gels in TBE buffer. Gels were dried on filter
papers and 32P activity corresponding to the mutant and target
eDNA band was quantitated on a Model GS-250 Molecular
Imaging System, (Bio-Rad, Hercules, CA, USA). 32P activity in
the mutant band was normalized by size and plotted against the
copies of DNA added. Linear regression analysis of the log plots
was performed using a minimum of 5 points to construct a
standard curve. The amount of target cDNA in a test sample was
determined by the intersection with the standard curve. To correct
for variations in RNA recovery and reverse transcription effi-
ciency, the amount of al(I) and a2(I) eDNA was normalized
against the amount of GAPDH eDNA derived from each sample.
Amplification of eDNA derived from other species
In order to determine whether the selected primers described
above would successfully and efficiently amplify cDNA from
murine, rat and human tissues, 20 .tg total RNA isolated from
whole mouse kidneys, whole rat kidneys or human kidney cortex
were reverse transcribed as described above. Serial log dilutions
were prepared and aliquots amplified as described above.
Experimental model of anti-GBM disease in the rabbit
Crescentic nephritis was induced in rabbits as previously de-
scribed [12, 131. New Zealand White rabbits (2.0 to 2.5 kg) were
injected subcutaneously with 200 j.rg guinea pig IgG in complete
Freund's adjuvant and five days later they were given a single
intravenous injection of guinea pig anti-rabbit glomerular base-
ment membrane (anti-GBM) IgG. To obtain a range of injury
rabbits received an intravenous injection of guinea pig anti-
glomerular basement membrane (anti-GBM) IgG (35 to 55 mg in
I ml of saline). All times were noted as the number of days
following injection of anti-GBM antibody. For experiments to test
the CI:G methodology, rabbits were euthanized with sodium
pentobarbital at day 7 and the kidneys removed for analysis at that
time. For the studies designed to test the predictive capacity of the
C1:G ratio rabbits were biopsied at day 7 and euthanized with
sodium pentobarbital at day 30. Rabbits were kept in individual
cages and were given water and regular rabbit chow ad libitum.
For biopsy rabbits were anesthetized with ketamine (Ketaset®;
Fort Dodge Laboratories Inc., Fort Dodge, JO, USA) and xyla-
zine (Rompun®; Miles Inc., Shawnee Mission, KS, USA). After a
flank incision, the left kidney was exposed. Renal cortical tissue
was obtained by a polar resection of approximately 30 mg of tissue
from under the renal capsule. Following biopsy the wound was
sutured and animals returned to their cages where they recovered
under observation. Thus, biopsy samples for the prediction exper-
iments contained renal cortex and did not contain renal capsule.
A total of 36 rabbits were used for the prediction experiments.
Two separate experiments were performed and the data were
measured separately and then combined for analysis. Eight rabbits
(four in each experiment) were not injected and were used as
controls. Eight rabbits died from presumed acute renal failure and
were not included in the analysis. Twenty experimental rabbits
survived the 30 day period of follow-up and were used for the
analysis together with the eight control animals.
For RNA preparation from biopsies, cortical tissue, weighing
approximately 5 to 6 mg, was transferred to guanidinium thiocy-
anate buffer (RNAzol B; Tel-Test, Inc., Friendswood, TX,
USA), frozen in liquid nitrogen immediately and stored at —80°C
until processing. Tissue was placed in 10% neutral buffered
formalin for light microscopic analysis.
Histopathologic analysis
All histologic analysis was done by an individual blinded to the
treatment of animals. There were two Day 7 histologic scoring
systems.
(i) Glomerulus score. A light microscopic scoring system using
Masson-trichrome-stained sections was performed as previously
described [11, 371. The extent of progression towards fibrocellular
crescent formation was scored from 20 consecutive glomeruli on
the renal biopsy obtained at day 7. Scoring was as follows: +0
glomeruli within the normal range; + I intraglomerular tuft cell
accumulation scored according to the degree of cellular accumu-
lation within the tuft; +2, proteinaceous material in Bowman's
space scored according to the amount of accumulation; +3,
cellular crescents in Bowman's space scored according to the
number of cells and the size of the cellular crescent; +4, fibro-
cellular crescents scored according to the degree of matrix
accumulation within the crescent and the glomerulus; and +5,
global glomerulosclerosis.
(ii) Interstitial score. Interstitial inflammatory changes were
graded 0 to 3 [normal (0), mild (1), moderate (2), severe (3)] by
evaluating five separate low power fields (bOX) of the biopsy and
taking the mean of these five scores.
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181 T V L H D G C T S H P G P W G K P V I E
3016 TACAAAACCACCAAGTCCTCCCCCTGCCCATCAPCGATGTGGCCCCCTTGGACGTTGGT
11111 111111111 IIIIIIIIIIIIIIIIIIII1IIII tIItiitIIIIl 1111
601 TACAAGACCACCAAGACCTCCCGCCTGCCCATCAPCGATGTCGCCCCCTTGGACATTGGC
201 Y K P T K P S R L P I I D V A P L D I G
3076 GCCCCAGACCAGGAATTC 3093
111111111 liii lilt,
661 GCCCCAGACCAGGAMTC 678221 A P D Q H F 226
Fig. 1. (A). Rabbit al(I) procollagen nucleotide sequence. The human al(I) procollagen cDNA sequence numbered as in Bernard [19, 20], Genbank
Accession #KM 228 (upper) is aligned with the rabbit al(I) procollagen eDNA sequence (lower) and the deduced rabbit ai(I) C-propeptide sequence.
The sequence of the primers were chosen to be identical in rabbit, human, rat and mouse(arrows).
I
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Fig. 1. (B) Confirmation that the primers
chosen would serve to amplify across species.
Autoradiogram of RT-PCR products developed
using the al(I) primers using reverse
transcribed samples of RNA from human, rat
and mouse renal cortex. The dilution factor is
the log dilution made of the eDNA preparation
prior to amplification by PCR.
Day 30 histologic scoring systems
Kidney sections were scored on Masson-trichrome stained
sections as previously described [11, 37].
(i) Percentage of crescents (% crescent score). The portion of
glomeruli with cellular or fibrocellular crescents in 75 to 100
consecutively evaluated glomeruli was counted. Only those that
were greater than 50% of the glomerular circumference were
scored. For this analysis, proteinaceous fibrin-containing material
in Bowman's space was not counted as a crescent.
(ii) Fibrosis score. The degree of cortical fibrosis was assessed on
Masson-trichrome-stained sections and graded 0 (normal), 1
(mild), 2 (moderate) and 3 (severe) based on the total amount of
blue stain throughout the cortex. This analysis included blue
staining in both glomerular and interstitial compartments. Five
areas were assessed and the mean of these five areas used as the
score.
(iii) Morphometric quantitation of interstitial compartment (%
interstitial fibrosis). The interstitial area that stained blue on
Masson-trichrome stained sections was measured using mor-
phometry as previously described [38]. Only the interstitial com-
partment was assessed by this approach. The data are expressed as
percent of total area that was occupied by Masson-trichrome-
stained blue matrix.
Cortical hydroxyproline measurement
Cortical collagen content was measured biochemically as total
hydroxyproline (OH-Pro) by the method of Phan et al [39].
Briefly, aliquots of weighed renal cortical tissue suspended in 6 N
HCI were hydrolyzed overnight at 110°C in tightly capped tubes.
The samples were then dried in a speed vac concentrator and
resuspended in citrate-acetate buffer (pH 6.0). The sample was
oxidized by chloramine T (Kodak Co.), mixed with p-dimethyl-
aminobenzaldehyde, and absorbance at 550 nm was measured.
Hydroxyproline content was calculated from a standard curve of
purified hydroxy-L-proline (Sigma Chemical Co.). Results were
expressed as hydroxyproline per mg dry weight.
Renal function measurements
Serum creatinine and urine protein and ereatinine were mea-
sured by routine methods in a clinical laboratory [37].
Statistical analysis
Data were expressed as mean SEM. Paired t-tests were
performed between groups for Table 1. Multiple regression
analysis was used to examine the relationship between indepen-
dent variables in relation to designated dependent day 30 vari-
ables.
RESULTS
Sequence for rabbit al(I) procollagen cDNA
Since we have extensive experience with a rabbit model of renal
scarring (anti-GBM disease) we chose to develop the RT-PCR
methodology in the rabbit. As a first step towards developing the
assay, we cloned a 3 kb fragment of the 3' end of rabbit al(I)
procollagen from a A-Zap renal cortical eDNA library (Strat-
agene) using a human al(I) eDNA probe (Methods). Figure 1A
shows the rabbit nucleotide sequence compared with the corre-
sponding human nucleotide sequence (nucleotides 2416-3093) for
a region at the 3' end of the eDNA [24—26]. Following additional
comparisons with known mouse and rat nucleotide sequences [13,
24—26, 28, 29, 40], primers were chosen (see arrows) that would
span an intron in the genomic sequence so that contaminating
DNA in samples would not be amplified efficiently and could be
identified by their larger size if present. That the chosen primers
would efficiently amplify reverse transcribed RNA from human,
mouse and rat as well as rabbit was also confirmed (Fig. 1B). This
same fragment of the al(I) procollagen eDNA was used for
Northern blots of rabbit RNA (see below).
GAPDH as a housekeeping gene for purposes of comparison
between samples and correction for sample size
A variety of housekeeping gene products have been used to
normalize mRNA levels, including f3-actin, GAPDH and cyclo-
phylins. We have previously reported that -actin mRNA is
increased as much as sevenfold in the renal cortex during inflam-
mation and would therefore not be a satisfactory housekeeping
gene [12]. To test the possibility of using GAPDH as a house-
keeping gene, we performed Northern blots comparing RNA
samples from cortex and medulla of a normal rabbit compared
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Fig. 2. Confirmation that GAPDH would serve
as a housekeeping gene in the rabbit renal
cortex. Northern blots of RNA purified from
control and nephritic kidneys were hybridized
with rabbit al(l) and GAPDH eDNA probes.
There was a marked increase in al(I) collagen
mRNA in nephritic kidney (day 7) as compared
with control kidney (day 0). GAPDH served as
a control for even loading of RNA. Note the
relatively much larger amount of collagen I
—— 1 8S mRNA in the nephritic samples compared with
the control samples. There was a marked
gradient of al(l) mRNA abundance between
cortex (C), outer medulla (OM) and inner
medulla (IM) in nephritic kidney. The presence
of renal capsule in the sample (C+) did not
obviously increase the abundance of al(I)
mRNA when compared with cortex alone (C).
cDNA probes for al(1) procollagen and GAPDH mRNA. Figure
2 shows that the amount of GAPDH mRNA did not change
significantly between normal and inflamed renal cortex, although
there were major changes in al (I) procollagen mRNA in the same
samples. This result confirmed that GAPDH would serve well as
a housekeeping gene for the assay.
Analysis of the collagen I mRNA levels in different
compartments of the kidney
In performing a renal biopsy, it is not easy to guarantee that no
renal capsule or medullary tissue is included in a given sample of
renal cortex. Furthermore, one might expect that the capsule or
medulla might contain a higher abundance of type I collagen
mRNA. We therefore wished to analyze what the potential
contribution would be if renal capsule or medulla was included in
a biopsy sample for measurement of collagen I mRNA. To assess
this point we removed whole kidneys from normal and nephritic
rabbits and collected samples with and without capsule from renal
cortex and from outer and inner medulla of the kidney under
direct vision. RNA was extracted and Northern blots were done
using the 1 (I) procollagen eDNA probe. As shown in Figure 3,
the amounts of collagen I mRNA in normal kidney were similar in
renal cortex and medulla. While the RNA preparation from renal
capsule itself contained relatively large amounts of collagen I
mRNA, the renal cortex sample that contained a cross-section of
capsule (C+) was not markedly different when compared with the
sample from which the capsule had been stripped (C).
We therefore concluded: (i) that the relative amounts of
collagen I mRNA in normal renal cortex and medulla are similar,
so that a small amount of contamination by renal medulla would
not have a major impact on the amount of collagen I mRNA
measured in a cortical sample; and (ii) that despite the high
abundance of collagen I mRNA in renal capsule, the presence of
a cross section of renal capsule would not have a major impact on
the amount of collagen I mRNA measured in the sample.
Effect of sample biopsy site in the nephritic kidney
We also wished to evaluate the potential effects of the sample
biopsy site in the nephritic kidney. Therefore, we obtained
samples from normal and nephritic rabbits at open biopsy from
renal cortex with (C+) and without (C) renal capsule and from
outer and inner medulla and performed Northern analysis (Fig.
2). There was a marked increase in collagen I mRNA in renal
cortex of nephritic rabbits. As noted for normal renal cortex, the
presence or absence of' capsule did not have a major effect on the
amount of collagen I mRNA measured in cortical samples.
However, there was clearly a difference between cortex and
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Fig. 3. Relative amounts of al(I) procollagen
mRNA in different compartments of the normal
kidney. Northern blots of RNA purified from
normal rabbit kidney were hybridized with
ol(T) procollagen and GAPDH cDNA probes.
Ten micrograms of RNA were loaded for each
sample except for the renal capsule (CAP),
which was loaded with one microgram of RNA.
RNA samples were prepared from renal cortex
including the capsule (C+), rcnal cortex minus
the capsule (C), outer medulla (OM) and inner
medulla (TM). Although the al(I) mRNA is
very abundant in renal capsular RNA, there
was little difference in abundance of al(T)
procollagen mRNA in renal Cortex with or
without capsule, reflecting the fact that the
capsular RNA represents a small proportion of
renal cortical RNA. Similarly, the amount of
al(1) procollagen mRNA in renal medulla was
approximately similar to that in renal cortex.
Thus, contamination of a biopsy sample by
capsule or medulla would not be expected to
markedly increase the amount of al(I)
procollagen mRNA measured in a sample.
induced by the anti-GBM antibody (crescentic glomerulonephri-
tis) is primarily in the cortex.
We conclude from these experiments that (i) sampling through
the renal capsule in the nephritic kidney is probably not of major
importance, and (ii) obtaining the sample from the renal medulla
in a case of cortical inflammation would probably serve to
underestimate the amount of collagen mRNA. Thus, some type of
confirmation of the site of the biopsy would he required for the
assay system. These results encouraged us to pursue measurement
of type I procollagen mRNA as an assay of collagen biosynthesis
in biopsy samples.
Range of injury in relation to amount of collagen I and
GAPDH mRNA present in renal cortex
Rabbits were injected with different amounts of anti-GBM IgG
(0.35, 0.45 and 0.55 mIs of a 10 mg/ml preparation). At day 7
rabbits were euthanized and the RNA extracted from renal cortex
and analyzed by Northern blot probed with the al(l) procollagen
eDNA probe. As is shown in Figure 4, the range of collagen I
mRNA present at different levels of injury in this experiment was
6-fold, 9-fold and 25-fold above normal in three rabbits receiving
increasing doses of anti-GBM antibody. No significant change in
GAPDH signal was seen. We conclude that large changes in
collagen I mRNA occur related to the amount of anti-GBM
antibody injected and severity of inflammation induced.
Quantitative RT-PCR methodology
(i) Primers. Selection and rationale. Primers for al(I) and cs2(I)
procollagen were chosen to amplifi a sequence coding for the
C-propeptide. The primers were chosen to amplii sequences of
537 hp, 460 bp and 527 bp for al(I) and a2(I) procollagens and
GAPDH, respectively (Methods). Each of these sequences
spanned an intron so that contaminating genomic DNA in RNA
samples would not be amplified efficiently. Primer sequences were
chosen that were identical between rabbit, human, mouse and rat.
Thus, the same primer pair and mutant template could be used in
a variety of experimental animal species (Fig. 1B). Each primer
pair was chosen to have a similar annealing temperature so that
assays could be performed simultaneously in a single thermal
cycler.
(ii) Mutant templates. Construction and rationale. To allow
quantitation of eDNA by PCR, we constructed internal standards
(mutant templates) that were identical to the sequence to be
assayed with the exception of a small internal deletion. This










Fig. 4. Dose-dependent effects of anti-GBM antibody on collagen I
expression in nephritic kidneys. Rabbits were administered different
doses of anti-GBM antibody (0.35, 0.45 and 0.55 ml of the anti-GBM IgG
preparation in a volume of 1 ml saline). RNA was isolated from renal
cortex at day 7. Northern blots (10 jig per lane) demonstrated a
dose-dependent increase in ul (I) collagen mRNA abundance. There was
little difference in hybridization of the GAPDH probe between control
and nephritic preparations.
deletion was sufficiently large to allow resolution of the mutant
sequences (433 vs. 537, 349 vs. 460 and 420 vs .527 bp for the
al(l), cx2(I) and GAPDH, respectively) from the wild type
sequences by polyacrylamide gel electrophorcsis, and yet close
enough in size to the wild type sequence to allow amplification
with a similar efficiency.
(iii) Assay sensitivity. Assays were set up so that a constant
amount of reverse transcribed eDNA was amplified in the pres-
ence of a variable amount of oiutant template. Figure 5 shows
representative results for each of the three cDNAs assessed. The
limit of sensitivity of the assays under the conditions used was
approximately 125 molecules of eDNA. The assay was linear over
the range 125 to 3,000 copies.
(iv) Use of GAPDFI to correct for variation in reverse transcription
of RNA and sample size. As noted above, the GAPDH mRNA
amount was shown not to vary significantly in spite of a large
variation in the amouot of collagen I mRNA in nephritic kidney
samples. Since it is difficult to reproducibly extract and reverse
transcribe RNA from small tissue samples, we elected to express
data as a ratio of collagen I eDNA molecules in a sample to the
number of GAPDH eDNA molecules in the same sample pro-
cessed in an identical manner and at the same time. This ratio is
referred to as the collagen I:GAPDH ratio or the CI:G ratio.
(v) Reproducibility of the assay. To assess the coefficient of
variation of all steps of the assay system, samples of renal cortex
were processed for the assay as described in the Methods section
on three separate days. The values obtained for the collagen I
mRNA levels for the sample for a nephritic kidney in experiments
performed on three days were as follows: Day 1: 4.57, 4.09, 4.85,
4.95. Day 2: 3.99, 4.06, 3.91. Day 3: 3.98, 3.87, 3.54. The mean
value for the ten assays was 4.18 0.46 giving a coefficient of
variation for the assay of 10.9%.
Biopsy sample size required to obtain reproducible values for
CI:G ratio
To assess the size of the biopsy required for reproducibility of
the assay, biopsies of various sizes were made from renal cortex of
rabbits with variable severity of nephritis. Because of the sensitiv-
ity of the assay system it was possible to use very small sample
sizes. Initial experiments used approximately 1 to 2 mm long
fragments of cores made with a 20 gauge needle (approximately
0.2 mg tissue wet wt). Four to five independent measurements of
the C1:G ratio were made each from an individual biopsy from
four animals. These included a control rabbit and rabbits injected
with variable amounts of anti-GBM antibody to induce mild,
moderate and severe crescentie nephritis and interstitial inflam-
mation. The results are shown in Table 1.
The coefficient of variance (CV) was highest in the animals with
mild and moderate injury (83.9 and 66.2%, respectively), where
some biopsies showed low C1:G ratios and some biopsies showed
high CJ:G ratios. The CV was lower in animals with no injury
(control) and with the most severe injury (24.3 and 32.5%,
respectively). We hypothesized that this wide range was because
we had used a small sample size and because there was hetero-
geneity of sites of collagen synthesis in the renal cortex, particu-
larly in the mild injury animals which had patchy inflammation
with a small proportion of glomeruli having crescents. Thus,
normal and severely injured animals would have more homoge-
neous injury while the mildly affected animals would have heter-
ogeneous injury that would not be averaged by the small biopsy
sample sizes.
To test this hypothesis we used larger sample sizes in an animal
with mild injury to determine whether this would give a more
uniform result with a lower coefficient of variance. When the
sample size was increased to approximately 2 mg (2 mm biopsy
sample from a 16 gauge needle) the CV was lower 02.7%) and
close to the 10.9% range previously measured for the assay.
We conclude from this series of studies that it is necessary to
use a piece of tissue at least 2 mg in size because of the
heterogeneity within the tissue itself Thus, particularly in the ease
of milder disease, very small samples that are easily within lhe
limits of sensitivity of the assay system may contain areas of
greater or lesser injury and collagen synthesis, and thus give a
wide range of values. Therefore, just as a large biopsy sample is
required for optimal histologic interpretation, a minimum of 2 mg
of tissue is required for reproducibility of collagen I mRNA
quantitation in this model.
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Fig. 5. Composite diagrams showing representative RT-PCR assays for the three mRNAs being quantitated (al(I) procollagen, a2(I) procollagen and
GAPDH). A) PAGE of the PCR products was performed and autoradiograms were prepared. A constant amount of wild-type (WT) eDNA was mixed
with a varying amount (125 to 3,000 copies) of the truncated mutant template (MT). Controls included lanes where no template was added or where
only WT or MT template was added. (B) The radioactivity in each band was quantitated on a phosphoimager and plotted against the copy number.
Linear regression analysis indicated an r2 varying between 0.97 and 0.99. The signal obtained with the wild type template was essentially constant over
this range of mutant template copy number. The number of copies in the unknown sample was read from the point of intersection of the WT (•) and
MT (E) lines.
Validation of the assay in a model of renal scarring in the
rabbit
In order to test the potential power of the assay at predicting
outcome in terms of scarring, we induced renal cortical inflam-
mation of varying degrees in 16 rabbits. This was done with a
range of doses of anti-GBM antibody to induce a wide range of
injury and scarring by day 30, as shown in Figure 6. Four rabbits
received no anti-GBM injections and acted as controls. At day 30
the proportion of glomeruli that contained fibrous crescents
ranged from 1% to 78% and cortical hydroxyproline content
increased as much as fourfold above baseline in some animals.
Therefore, the range of injury and scarring produced by the
experimental model under the conditions used was adequate to
test the predictive capacity of the Cl:G ratio.
We have previously examined the outcome parameters in this
model and found that a biochemical measure of outcome (cortical
hydroxyproline per dry weight of renal cortex) is a good overall
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Fig. 6. Photomicrographs of Masson-Trichrome-stained histologic sections of rabbit renal cortex at day 30. The photomicrographs illustrate normal
(A), mild (B), moderate (C) and severe (D) injury with scarring. Sections labeled B, C and D show progressively more interstitial blue-stained matrix
in association with a progressively greater proportion of glomeruli showing fibrous-cellular crescents. Conversely, the proportion of "normal"-appearing
glomeruli progressively decreases from 5/6 in B, to 3/6 in C to 1/5 in D. The bar represents 100 .rm.
renal cortex, it is quantitative, and it does not depend on a scoring
system [37]. Therefore, we compared CI:G ratios with this bio-
chemical measure. Rabbits were biopsied at day 7 by open
surgery, at which time a piece of cortex without renal capsule was
surgically removed from one pole of the left kidney. This biopsy (5
mg) was processed for RNA extraction and RT-PCR as described
in the Methods section. The rabbits were then left until day 30
when they were killed and the right (unbiopsied) kidney was
removed for quantitation of hydroxyproline per dry weight.
(i) Coefficient of determination of the LG assay for hydroxypro-
line accumulation in renal cortex in the rabbit model of anti-GBM
disease. Figure 7 shows a plot of the Cl:G ratios for al (I) and
n2(I) procollagen at day 7 versus cortical hydroxyproline per dry
weight at day 30. The coefficient of determination was surprisingly
high at 0.89 for 1(l) and 0.90 for 2(I) C1:G ratios, respectively.
This high correlation is probably because we biopsied the animals
at the peak of their inflammatory response to the anti-GBM
antibody, and one would predict that this would he closely related
to outcome. Nevertheless, given that the coefficient of variation of
the assay was 11%, it was surprising to get such a powerful
predictive capability in a biologic system. This result suggests that
the steady-state collagen I mRNA level at day 7 is a very
important factor in determining or is closely linked to a factor that
determines the amount of fibrosis that occurs in the model.
(ii) The relative utility of measuring a] (I) procollagen versus a2(I)
procollagen mRNA as an index of potential interstitial scarring.
There are two to three times as many copies of al(I) as there are
of a2(I) procollagen mRNA in tissue (Fig. 7). Furthermore, a
comparison of the data for the alCI:G and a2CI:G ratios in
Figure 7 shows that there was more scatter for a2CI:G than for
alCI:G at lower levels of inflammation. Thus, it appears that
measurement of al(T) procollagen mRNA may provide a more
sensitive and reproducible index of potential collagen synthesis
than would measurement of a2(I) procollagen mRNA, at least as
judged by the rabbit model used for this study. For subsequent
analysis we therefore used the alCl:G ratio.
Prediction experiments using the anti-GBM model of renal
scarring and comparison of the C1:G ratio with other clinical
parameters
To achieve a wide range of scarring at day 30 variable amounts
of anti-GBM antibody were injected as described above. Two
separate experiments were done and the data combined for the
analysis. Rabbits were obtained at day 30 with the percent of
fibrous crescents ranging from 1% to 82% and the degree of
cortical hydroxyprolinc content increasing up to fourfold above
baseline.
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Fig. 7. Relationship between the CI:G ratio at day 7 and cortical
hydroxyproline content at day 30. Plots of the C1:G ratios for al(I) (A)
and a2(I) (B) procollagens measured at day 7 of the model of anti-GBM
disease against cortical hydroxyproline per mg dry weight at day 30 of the
model. The correlations of determination (r2) for the alCI:G and a2CI:G
ratios were 0.89 and 0.90, respectively, suggesting a close relationship
between collagen mRNA levels at day 7 and amount of collagen at day 30.
Note the difference in copy number for al(I) versus a 2(I) procollagen
mRNAs.
Four separate measures of fibrosis outcome were quantitated at
day 30 of the model: (a) an overall histologic fibrosis score from
Masson-Trichrome stained sections; (b) a morphometric quanti-
tation of interstitial matrix staining; (c) the proportion of glomer-
uli that contained fibrous crescents (% crescents); and (d) the
biochemical measure of collagen accumulation (cortical hy-
droxyproline content factored per unit dry weight of renal cortex).
There was good correlation between these outcome parameters
(r = 0.80—0.84) as reported previously in this model [38].
Serum creatinine and urine P/C ratio are poor measures of
established renal injury
Serum creatinine concentration is the most commonly used
method of monitoring the level of renal function, in spite of its
well-known limitations [6—91. These limitations are highlighted by
the plots shown in Figure 8 where the lack of sensitivity of serum
creatinine measured at day 30 to detect more than 40% fibrous
crescent formation in some animals is shown. This result is not
surprising given the fact that removal of a kidney results in little
change in serum creatinine in clinical practice.
The urine P/C ratio at day 30 was also an insensitive measure of
the amount of established injury in the kidney at day 30 (Fig. 8).
This parameter only became reliably abnormal when more than
40% of glomeruli had fibrous crescents and when the level of
scarring was very significantly increased.
Capacity of parameters measured at day 7 to predict outcome
(scarring) at day 30
The day 7 parameters evaluated included two functional pa-
rameters (serum creatinine and urine P/C ratio), two histologic
parameters (glomerular and interstitial scores) and the CI:G
ratio. Correlations of determination (r2) for the day 7 parameters
against day 30 outcome parameters of fibrosis (cortical hy-
droxyproline, percent crescents, percent interstitial fibrosis and
fibrosis score) are shown in Table 2. The mean coefficient of
determination for the four different scarring parameters was also
calculated (Table 2). The mean predictive values for each of the
day 7 parameters were as follows: 49% for serum creatinine, 49%
for urine P/C ratio, 62% for glomerular histologic score, 66% for
interstitial score and 69% for CI:G ratio.
To determine whether combinations of day 7 parameter would
have increased predictive power, multiple regression analysis was
performed with each of the day 30 outcome parameters desig-
nated as the dependent variable (Table 2). The combination of
the two clinical parameters (AB) gave a mean r2 of 0.67, while the
combined histologic parameters (CD) gave a mean r2 of 0.69. The
combination of clinical plus histologic parameters (ABCD) gave
further improvement with a mean r2 of 0.76. Addition of the CI:G
ratio (E) to any of these groups significantly improved to predic-
tive capacity of each of the combinations by about ten percent.
Thus, the coefficient of determination (r2) for ABCDE was
significantly higher than ABCD (0.84 vs. 0.76, P <0.02); ABE was
higher than AB (0.80 vs. 0.67, P < 0.01); CDE was higher than CD
(0.79 vs. 0.69, P < 0.02); AE was higher than A (0.77 vs. 0.49, P <
0.02). Thus, the CI:G ratio contributes information not included
in the other measurements, and this significantly improved ability
to predict outcome in the model.
Table 3 shows the relative power of each variable measured at
day 7 to predict outcome at day 30. For this analysis each outcome
variable was again designated as the dependent variable and the
relative weight (P value) of all five day 7 variables was calculated.
The coefficient of determination for the combined day 7 variables
is also shown in Table 3. For percent crescents at day 30 the
statistically significant predictive factors were CI:G ratio P =
0.0002), serum creatinine (P = 0.002) and glomerular score (P =
0.04). The urine P/C ratio and the interstitial score did not
contribute significant additional information in the analysis. For
percent interstitial fibrosis the major factors were CI:G ratio (P =
0.02) and urine P/C ratio (P = 0.02). For the fibrosis score they
were CI:G ratio (P = 0.02) and interstitial score (P = 0.02). For
cortical hydroxyproline they were CI:G ratio (P = 0.0005) and
urine P/C ratio (P = 0.02). The CI:G ratio was the only predictor
that was found to be statistically significant (P < 0.05) for all
outcomes measured. This analysis also supports the conclusion
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information not provided by the clinical or histologic parameters mild vs. scvere). Animals were divided into groups based on the
in the model tested, proportion of glomeruli that had fibrous crescents at day 30 (%
crescents at day 30) as shown in Table 4. This outcome was chosen
Group analysis of data as defined by severity of glomerular as the end point because the anti-GBM model targets the
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Serum creatinine at day 30 Urine P/C ratio at day 30
Fig. 8. Plots showing the relationship between functional parameters [(A, B) serum creatinine concentration (LI) and (C, D) urine protein:creatinine
ratio.] and outcome parameters (hydroxyproline and percent fibrous crescents) all measured at day 30. Up to 50% crescents and marked increases
in cortical hydroxyproline occurred without increases in serum creatinine or urine P/C ratio as measured at day 30.
Table 2. Coefficients of determination (r2) assessed by multiple regression for the dependent outcome parameters at day 30 in relation to the
independent predictive parameters and combination of parameters measured at day 7
















Crescents fibrous % 0.67 0.43 0.76
Interstitial fibrosis % 0.25 0.59 0.48
Fibrosis score 0.58 0.41 0.70
OH-Praline Per Wt. 0.44 0.51 0.52
Mean r2 0.49 0.49 0.62
Combinations of day 7 parameters
The mean r2 value for the four fibrosis outcome measures combined is also shown.
Interstitial CI:G Effect of CI:G ratio (E)
score ratio Clinical Histologic Clin/Hist
D E AB CD_—_ABCD AE ABE CDE ABCDE
0.73 0.69 0.73 0.78 0.85 0.87 0.87 0.88 0.92
0.54 0.63 0.60 0.54 0.63 0.66 0.71 0.63 0.72
0.77 0.70 0.65 0.78 0.82 0.77 0.78 0.83 0.86
0.61 0.72 0.68 0.65 0.72 0.77 0.85 0.80 0.85
0.66 0.69 0.67 0.69 0.76 0.77 0.80 0.79 0.84
We examined the hypothesis that individual day 7 parameters
might discriminate better over a particular range of injury (such as
regression analysis had shown that this variable was the major
determinant of injury [37]. Groups were designated to include
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Table 3. Multiple regression analyses (P values)
Independent variables (day 7)
Serum Coefficient of
Dependent fibrosis creatinine Urine P/C Glomerular Interstitial mRNA determination
outcome variables mg/dl ratio score score CI:G ratio r2
% Fibrosis crescents 0.002 I 0.38 I 0.04 I 0.80 0.0002 I 0.92
% Interstitial fibrosis 0.55 I 0.02 I 0.90 0.83 0.02 0.72
Fibrosis score 0.04 0.33 0.93 I 0.02 0.02 0.86
OH-proline per wt 0.33 I 0.02 I 0.85 0.63 I 0.0005 I 0.85
Multiple regression analysis showing the P values for the contribution of each day 7 parameter to predict each day 30 fibrosis outcome parameter
(designated as a dependent variable for regression analysis). The coefficient of determination (r2) for the combined multiple regression analysis for each
fibrosis Outcome is shown. P values of <0.05 are shown in boxes.
Table 4. Group analysis on the basis of the proportion of glomeruli
that develop fibrous crescents at day 30 with reference to Figure 9
Descriptor
% Fibrous crescents
Mean SCM Range N
Serum creatmine mg %
Day 7 Day 30
Normal 0 0 (1 8 0.9 0.1 1.0 0.1
Mild 2.5 0.7 1.4—3.7 3 1.1 0.1 1.1 0.1
Moderate 21.4 3.8 10—35 6 1.7 0.2 1.3 0.1
Severe 47.4 3.7 36—62 7 5.7 1.3 3.4 1.3
Very severe 76.9 2.2 71—82 4 6.4 1.1 5.4 2.1
animals with 0, <10% and a mean of approximately 25%, 50%
and 75% crescents. Table 4 outlines groups that include the
descriptions normal, mild, moderate, severe and very severe injury
together with serum creatinine values for each group at day 7 and
day 30. The groups correspond to commonly seen clinical subsets
of renal injury.
We wanted to determine the relative power of the variables
measured to discriminate over the whole range of injury. The
variables measured at day 7 were plotted against the different
injury groups at day 30 (Fig. 9). The result of this analysis for the
day 7 variables can be summarized as follows: (a) Serum creati-
nine was a good discriminator between moderate to severe injury
but was insensitive at either end of the scale and there was a large
variation at higher grades of injury. (b) Both the urine P/C ratio
and glomerular score were particularly sensitive indicators of mild
injury. (c) The interstitial score at day 7 was a good discriminator
for mild to severe injury. (d) The CI:G ratio discriminated well
over the whole range of injury.
All groups had erythrocytes and RBC casts in the urine (data
not shown). Thus, the presence of erythrocytes and RBC casts is
a sensitive indicator of glomerular injury, but like urine P/C ratio
and glomerular score did not provide a reliable indicator of the
severity of injury.
DISCUSSION
In setting up the C1:G assay we predicted that other factors
which drive collagen synthesis (such as TGF-f3) and factors that
regulate collagenolysis (such as metalloproteinases and inhibitors
of collagenases like TIMP5) would play a significant role in the
extent of collagen accumulation in the model. We therefore
anticipated that a useful assay system might need to measure
these parameters in addition to the CI:G ratio in order to provide
a useful predictive index. From the data provided in this report it
appears that, at least in the model described, the collagen I
mRNA level alone provided a powerful predictive index of
collagen accumulation. In other systems it may well be necessary
to measure other parameters to predict outcome with a high
degree of accuracy.
Measurement of the amount of established scar in a biopsy by
histologic stains (such as chronicity score assessed using Masson-
Trichrome-stained histologic sections) provides an index of the
amount of injury sustained in the past. It does not provide
information about whether the current therapeutic strategy has
successfully turned off progressive injury and the scarring process.
Histologic scoring systems have used a combination of quantita-
lion of prior scar formation ("chronicity" index) as well as an
"activity" score to indicate the level of current inflammation and
injury [11]. Although these scoring systems are helpful they are
imprecise. Furthermore, in the experiments described here there
was no prior injury. The biopsy interpretation was therefore
relatively simple because it was superimposed on a previously
normal renal cortex. This is frequently not the case in human
disease where chronic and repetitive events have built one upon
the other to create a picture that is even more difficult to interpret.
The Cl:G ratio would theoretically have the potential to provide
additional information, namely the degree to which the scar-
forming machinery has been activated at a point in time and under
the influence of a particular therapeutic strategy. This information
should in theory be a useful adjunct to the histologic measure of
scar accumulation in an individual, and would allow the physician
to determine whether the current therapy was effective without
having to wait for changes in renal function to occur. It would also
facilitate the development of drugs that would target this process
specifically.
When tested in the rabbit anti-GBM model the CI:G ratio
proved to be as good or a better independent predictor of
outcome than the clinical variables (serum creatinine and urine
P/C ratio) or the histologic variables measured (glomerular and
interstitial activity scores). Furthermore, the CI:G ratio appeared
to provide additional information not available from the conven-
tional measures. Thus, the CI:G ratio could be a useful adjunct to
conventional predictive parameters of function and histology.
Serum creatinine proved to be an insensitive measure of
established scarring in the kidney in these experiments, as is well
known from previous reports [6—9]. It could be argued that
accurate measures of GFR at day 7 by use of iothalamate or other
approaches might have provided a better predictor of collagen
accumulation at day 30. However, GFR is difficult to measure
accurately in acute renal injury in clinical practice. We therefore
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Fig. 9. Plots showing the relationship between the severity of injury at day 30 (horizontal axis) and each parameter measured at day 7 for groups of
animals based on their level of injury (% crescents) as defined in Table 4. Note that some parameters discriminate better at particular levels of injury.
The CI:G ratio was the only parameter that discriminated throughout the range of injury from normal to very severe. Abbreviations as defined in Table
4 are: Nml, normal; MId, mild injury; Mod, moderate injury; Sev, severe injury; VS, very severe injury. (A) Serum creatinine. (B) Urine P/C ratio. (C)
CI:G ratio; (I)) Glomcrular score. (E) Interstitial score.
chose to evaluate the CI:G ratio in relation to current methods in
common use in the clinic.
The CI:G ratio would probably not be necessary for clinical
decision making iii severe anti-inflammatory injury that would
require urgent and high doses of immunosuppressive agents.
Rather, we would anticipate that the Cl:G ratio might be partic-
ularly useful in chronic lower level injury such as might occur in
SLE, MPGN, diabetes, hypertension, allografts and IgA nephrop-
athy. Because of renal reserve and other factors, by the time a
significant increase in the serum creatinine has occurred, and has
been recognized, very significant nephron loss (up to 60% or
more) has often already taken place. This means that the window
of opportunity for treatment and prevention may already be three
quarters closed by the time diagnosis and specific treatment is put
in place.
Is it realistic to consider another component to the renal biopsy,
which is already a costly procedure? The potential utility of the
CI:G ratio or similar approaches must obviously he proven in
clinical trials. However, the opportunities for reducing cost and
mortality in renal disease are enormous. The current direct cost of
one year on dialysis is approximately $50,000US, and the associ-
ated mortality is 15 to 20% in the U.S. [51. Therefore, a strategy
that resulted in the delay of progression in an individual reaching
ESRD for one year would save $50,000US and/or 15 to 20% of a
life from dialysis costs and complications alone. Automated
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harnessed to produce an assay that would require little or no
human effort over and above obtaining the biopsy.
Seen in this light we cannot afford not to develop new ideas and
approaches to preventing progression to ESRD. We look towards
a future when the focus will he on early detection and intervention
to prevent progression of renal injuly before significant or even
measurable renal function has been lost. The CI:G ratio and other
approaches may prove cost-effective in the long term as we move
towards this goal.
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APPENDIX
Abbreviations used in this paper are: SDS, sodium dodecyl sulfate;
PCR, polymerasc chain reaction; GAPDH, glyceraldehyde-3-phosphate
dehydrogenase; CV, coefficient of variance.
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